Biotech Stocks Hitting Fresh Highs

Over the last year, the NASDAQ Biotechnology Index (NBI) has gained nearly 12%, while the iShares NASDAQ Biotech EFT (IBB) increased more than 12% and the SPDR S&P Biotech ETF (XBI) over 22%.  The biotechnology sector has is known for being one of the most exciting sectors in the markets, with the potential to generate immense profits practically overnight. Last year, U.S. drug approvals hit … Continue reading Biotech Stocks Hitting Fresh Highs

Biotech Stocks On The Rise

The fate and fortune of a biotechnology company typically relies on two events, results from clinical trials and FDA approval. Nonetheless, to get the most out of what these explosive stocks could potentially offer would mean knowing when these fundamental events are going to take place. Returns on investments in a biotech stock can be nothing less than impressive, if a position is taken at … Continue reading Biotech Stocks On The Rise

New Biotech Concept Has These Stocks Gaining Investors’ Attention

Typically, the stock market slows down towards the end of summer, but this year that has not been the case.  Big pharma is weighing in on clinical stage companies as smaller biotechnology companies are benefiting.  Moves by the FDA have brought even more attention to the industry. The recent collaboration between Affimed (AFMD) and Roche (RHHBY)/Genentech showed the market that tens of millions of dollars, … Continue reading New Biotech Concept Has These Stocks Gaining Investors’ Attention

Biotech Stocks: Closing Out The Summer Strong

Heading into the last few days of summer, it is bittersweet.  August has been a month of gains for the biotechnology sector as the ETF’s have been on fire. Yesterday, the Health Care SPDR ETF (XLV) hit new highs, for the fourth trading session in a row.  The fund has gained nearly 12% over the past three months while the S&P Pharmaceuticals ETF (XPH) is … Continue reading Biotech Stocks: Closing Out The Summer Strong

3 Biotech Stocks Trending This Week

The number mergers and acquisitions in the biotech sector has started to move closer to that of all-time highs of 2016. Last year, M&A deals in the sector totaled around $200 billion, led by deals from heavyweights Johnson & Johnson’s (JNJ) and Gilead Science (GILD). Analysts remain confident that this year should only exceed those numbers. This year has already started with a bang, as Big Pharma continues … Continue reading 3 Biotech Stocks Trending This Week

Biotech Stocks Moving On Clinical Trial News

The Nasdaq iShares Biotechnology Index (IBB) has recently been on an uptrend, touching its 52-week high off the open this morning.  The ETF rose more than 1.86% during Tuesday morning’s trading, setting the stage for several other biotech stocks to follow its lead. Furthermore, several other ETF’s tracking the sector were on the move during this morning’s session. The Health Care SPDR (XLV) recorded new highs while the S&P … Continue reading Biotech Stocks Moving On Clinical Trial News

Friday’s Top Biotech Picks

As this week’s political woes endure, it appears investors are still more concerned with the economy and corporate earnings, rather than President Trump’s legal issues. Although equities have slightly dropped, for the most part, they are still standing strong. The S&P 500 ETF (SPY) closed the day 0.1% lower on Thursday after changing between small gains and losses, while the Dow Jones Industrial Average ETF (DIA) took in a … Continue reading Friday’s Top Biotech Picks

3 Biotech Stocks Capitalizing On Industry Momentum

Once again, the biotechnology sector is heading higher on Tuesday.  The SPDR S&P Biotech ETF (XBI), iShares NASDAQ Biotechnology Index ETF (IBB) and Health Care SPDR ETF (XLV) are all green today. This continues to support the fact that biotech stocks have enjoyed respectable gains this year. The NASDAQ Biotechnology Index (IBB) reached new highs this year and has seen a 20 percent increase over … Continue reading 3 Biotech Stocks Capitalizing On Industry Momentum

3 Biotech Stocks That Could Skyrocket in 2018

The biotechnology sector has certainly become one of the most exciting sectors of the market. It is known for giving its investors substantial returns in a short period of time. Usually, it only takes one FDA catalyst to send their share prices soaring. Last year was a significant year for biotechs, U.S. drug approvals reached a twenty-one-year high. Forty-six novel medications gained approval, most in … Continue reading 3 Biotech Stocks That Could Skyrocket in 2018

3 Biotech Stocks With Potential In Their Pipelines

The increase of the aging population presents immense opportunities for bio-pharmaceutical companies to develop candidates to treat global ailments.  Dozens of biotech stocks continue to generate significant gains for investors and as the average lifespan continues to increase, the number of drugs being developed to hit the market should follow.  The potential for share prices to skyrocket instantaneously on favorable trial news or possible FDA … Continue reading 3 Biotech Stocks With Potential In Their Pipelines